Blaine Schamber

Corporate Controller at ArQule, Inc.

Blaine Schamber

Blaine Schamber

Corporate Controller at ArQule, Inc.

Biography

On March 15, 2019, ArQule, Inc. announced the appointment of Blaine Schamber as the Company's Principal Accounting Officer, effective March 29, 2018. Mr. Schamber currently serves as the Company's corporate controller, a position he has held since May 2015, and served as the company's assistant controller from 2007 until May 2016. Earlier in his career Mr. Schamber held various finance and accounting positions at AltaRex Corporation, Biomira, Deloitte and the Canadian Imperial Bank of Commerce. Mr. Schamber is a registered CPA and received his MBA and BSc (biochemistry) from the University of Alberta.

Overview
RelSci Relationships

44

Relationships
RelSci Relationships are individuals Blaine Schamber likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at ArQule, Inc.

Relationship likelihood: Average

President & Chief Operating Officer at ArQule, Inc.

Relationship likelihood: Average

Former Chief Financial Officer & Treasurer at ArQule, Inc.

Relationship likelihood: Average

Chief Medical Officer at ArQule, Inc.

Relationship likelihood: Average

Senior Director-Business Development at ArQule, Inc.

Relationship likelihood: Average

Chief Financial Officer & Head of Strategy at ArQule, Inc.

Relationship likelihood: Average

Vice President-Investor Relations & Corporate Communications at ArQule, Inc.

Relationship likelihood: Average

Clinical Operations Director at ArQule, Inc.

Relationship likelihood: Average

Senior Vice President, Program Management & Product Planning at ArQule, Inc.

Relationship likelihood: Average

Co-Founder at KensaGroup LLC

Relationship likelihood: Average

Paths to Blaine Schamber
Potential Connections via
Relationship Science
You
Blaine Schamber
Corporate Controller at ArQule, Inc.
Career History
Corporate Controller
Current

ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751, Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.

Other Affiliations

Blaine Schamber is affiliated with ArQule, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Blaine Schamber. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Blaine Schamber's profile does not indicate a business or promotional relationship of any kind between RelSci and Blaine Schamber.